Article info
PDFEditorial
Amyloid cerebrovasculopathies
- Correspondence to Professor N J Scolding, University of Bristol, Bristol, UK; n.j.scolding{at}bristol.ac.uk
Citation
Amyloid cerebrovasculopathies
Publication history
- Accepted February 24, 2022
- First published March 21, 2022.
Online issue publication
May 17, 2022
Article Versions
- Previous version (21 March 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum
- Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system
- Subtypes of primary angiitis of the CNS identified by MRI patterns reflect the size of affected vessels
- Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance
- Primary angiitis of the central nervous system: avoiding misdiagnosis and missed diagnosis of a rare disease
- Amyloid PET imaging in clinical practice
- South Wales Joint Neuroscience Meeting, Bridgend, 29 April 2010: a 66-year-old man who suddenly couldn't drive
- Cerebral amyloid angiopathy: an underdiagnosed cause of recurrent neurological symptoms
- Rapidly progressive dementia due to leukocytoclastic vasculitis of the central nervous system
- The diagnosis of primary central nervous system vasculitis